Drugs and Money: Prices, Affordability and Cost Containment
Maurice Nelson Graham Dukes
IOS Press, 2003 - Medical - 152 pages
This edition aims to provide policy makers and regulators with a compact and practical review of the various approaches that have been developed and tested to date in an effort to contain the overall costs of pharmaceutical services and drug treatment.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Drugs and Money
Data needed for developing and monitoring policies
Policy options for cost containment of pharmaceuticals
A H Rietveld and F M HaaijerRuskamp
Making use of economic evaluation
Experiences with budgets
Providing affordable medicines in transitional countries
List of Contributors
Other editions - View all
2002–World Health Organization ACE inhibitors approach assessment branded British Columbia budget CCEE clinical co-payment compared competition consumer cost containment cost-effective databases decision makers developing countries diseases dispensing drug classes drug costs drug expenditure drug policies drug prices drug utilisation DTC advertise economic evaluation effects ensure equity Essential Drugs essential medicines European evidence example financing fundholding Health Economics health outcomes health services health system impact implementation important increase indicators individual innovation interventions IOS Press Chapter limited manufacturers margins MCOs measures monitoring National Health Service negotiation Netherlands OECD overall parallel imports particular patients PBMs pharmaceutical expenditure pharmaceutical industry pharmaceutical market pharmacists pharmaco-economic pharmacy benefits management physicians population positive list practice prescribing prescription drugs problems professional programmes reference price system regulation reimbursement sector therapeutic treatment wholesalers World Health Organization Yes Yes Yes